Hepatitis Inequalities Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2031-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Health inequality in liver diseases including age, gender, ethnicity and socioeconomic status has been increasingly recognised and potentially hinder hepatitis elimination. Health inequality has significant impact to evaluate the impact diagnostic and treatment uptake rates of chronic viral hepatitis on risk of hepatocellular carcinoma (HCC), hepatic event and liver-related death in patients with chronic hepatitis B and/or C. To overcome the limitation of small prospective cohort study of limited recruitment period, retrieving information from the Clinical Data Analysis and Reporting System (CDARS) from Hospital Authority (HA) will be one of the best way to answer these questions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Linkage to Care and Treatment of Chronic HBV Patients

NCT06658678

Hepatitis B, Chronic

COMPLETED NA

A Comprehensive HBsAg-positive Patients Centered Screening Strategy

NCT03794791

Hepatitis B and Hepatitis C (Disorder)

COMPLETED

Seroepidemiology of Viral Hepatitis in Hong Kong

NCT04371276

Viral Hepatitis

COMPLETED

Biologic Basis of Liver Cancer From Chronic Hepatitis B

NCT03300414

Hepatocellular Carcinoma Hepatitis B, Chronic

COMPLETED

The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy

NCT01957618

Hepatitis B Virus-Related Hepatocellular Carcinoma

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis B HEPATITIS C VIRUS CHRONIC INFECTION

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients will be eligible if they have any of these viral markers (HBeAg / HBsAg / HBV DNA / HCV RNA) and/or any of the following diagnosis codes (ICD-9 070-070.9; 348.3, 349.82, 456, 456.2, 456.8, 567.2, 567.8, 570, 571.2, 571.5, 571.6, 572.2, 572.3, 572.4, 789.5) checked or coded in any public hospitals or clinics from 1 January 2000 to 31 March 2024.

Exclusion Criteria

* Patients with missing age, gender, ethnicity and socioeconomic status
* (Subgroup analysis for ethnicity and socioeconomic status) Patients with missing ethnicity and socioeconomic status
* Serious medical illnesses or malignancy with life expectancy \<1 year

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No